PPMS (Primary Progressive Multiple Sclerosis) patients rarely find local patient education events geared toward them. Since the FDA (USA) approved the first treatment effective for PPMS last year, PPMS patients have been receiving more opportunities to learn and more support.
Genentech, Manufacturer of Ocrevus (Ocrelizumab), is sponsoring patient education events across the US. There is an event in Florida in February. Vist their website to search for an event near you.